Tango Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:TNGX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 316.49 M274.31 M237.89 M210.14 M398.69 M 負債合計 116.97 M107.55 M102.94 M50.1 M52.51 M 純資産合計 199.52 M166.76 M134.95 M160.03 M346.18 M 負債および純資産合計 316.49 M274.31 M237.89 M210.14 M398.69 M 有利子負債合計 ————— 純負債 —————

ニュース

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

Tango Therapeutics株が17.64ドルで52週高値を記録

Tango Therapeutics stock hits 52-week high at $17.64

Stifel、PRMT5データを受けてTango Therapeuticsの目標株価を引き上げ

Stifel raises Tango Therapeutics stock price target on PRMT5 data

Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX)

TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS

Jefferies、RAS契約を受けてTango Therapeuticsの目標株価を引き上げ

Jefferies raises Tango Therapeutics stock price target on RAS deal

Tango Therapeutics, Up 39% This Year, Surges Again On Another Cancer Pact

Stifelが Tango Therapeutics株の目標株価15ドルで買い推奨を継続

Stifel reiterates Tango Therapeutics stock Buy rating at $15